HScore for Reactive Hemophagocytic Syndrome

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
hscore
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Very Low Risk0–90
  • Low Risk91–168
  • Intermediate Risk169–250
  • High Risk251–337
Direct Clinical Answer

The HScore for Reactive Hemophagocytic Syndrome calculates determining thromboembolic risk, heparin-induced thrombocytopenia probability, and bleeding diathesis. Key inputs include known immunosuppression. Scores guide initiating targeted anticoagulation therapy, platelet monitoring, or hematology specialist referral. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Estimates the risk of having reactive hemophagocytic syndrome (RHS) based on clinical, laboratory, and histologic findings. Uses nine variables to provide a probability score ranging from <1% to >99% for RHS diagnosis.

Clinical Indication

The HScore for Reactive Hemophagocytic Syndrome is indicated for bedside clinical practice to support Estimates the risk of having reactive hemophagocytic syndrome (RHS) based on clinical, laboratory, and histologic findings. Uses nine variables to provide a probability score ranging from <1% to >99% for RHS diagnosis.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.

Limitations & Contraindications

Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention.

Clinical Pearls & Action Plan

Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies. Guideline pearl: Reactive hemophagocytic syndrome is a life-threatening condition requiring urgent treatment.

Formula & Variables:

HScore = sum of weighted points from 9 variables: immunosuppression (0-18), temperature (0-49), organomegaly (0-38), cytopenias (0-34), triglycerides (0-64), fibrinogen (0-30), ferritin (0-50), AST (0-19), hemophagocytosis (0-35)

Input Parameters

NameTypeRequiredDescription
known_immunosuppressionstringYesPatient with known underlying immunosuppression
temperaturestringYesTemperature category
organomegalystringYesOrganomegaly (hepatomegaly or splenomegaly)
cytopeniasstringYesNumber of cytopenias
triglyceridesstringYesTriglyceride level(mg/dL)
fibrinogenstringYesFibrinogen level(mg/dL)
ferritinstringYesFerritin level(ng/mL)
ast_sgotstringYesAST/SGOT level(IU/L)
hemophagocytosisstringYesHemophagocytosis features on bone marrow aspirate

Score Interpretation & Guidance

RangeStageDescription
0–90Very Low RiskHScore ≤90
91–168Low RiskHScore 91-168
169–250Intermediate RiskHScore 169-250
251–337High RiskHScore >250

Evidence-Based References (EBM)

  • Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P, Hie M. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014 Sep;66(9):2613-20.
  • Debaugnies F, Mahadeb B, Ferster A, Meuleman N, Rozen L, Demulder A, Corazza F. Performances of the HScore in the diagnosis of hemophagocytic lymphohistiocytosis: a multicenter study. J Clin Med. 2021 May 17;10(10):2143.

Related calculators